Key executive appointment supports strategic operational delivery of the Company’s product and partnership programs
London, UK, 20 June 2023: Closed Loop Medicine Ltd., a leading TechBio company developing combination prescription drug plus software therapy products that enable personalized dose optimization, today announced that it has appointed Kate Woolland as Chief Operating Officer. Kate joins CEO, Dr. Hakim Yadi PhD OBE, on the executive team to guide organizational and operational delivery of the Company’s lead programs, products and commercial partnerships.…
Award-winning digital marketing agency Sookio marks 15th anniversary with a fresh strategic offering and launch of innovative work experience initiatives.
Founded in 2008 by Ely businesswoman Sue Keogh, the company’s ethos is to Untangle your thinking – helping ambitious and transformative organisations to communicate their ideas to the world through brilliant digital strategy, content, and training.
Sue comments:“We’re so proud of the work we’ve done for clients including the NHS, University of Cambridge, Huntingdonshire and South Cambs District Councils, the BBC, and Alzheimer’s…
This exclusive research collaboration with Eli Lilly and Company and Verve Therapeutics will focus on advancing Verve's preclinical stage in vivo gene editing program, targeting lipoprotein(a) (LP(a)) for the treatment of Atherosclerotic Cardiovascular Disease, through the completion of Phase 1 clinical development. Lilly will then be responsible for the subsequent development, manufacturing and commercialisation.
Read more
Source Genomics Expands Rapid Sanger Sequencing Services to the North of the UK
Cambridge, UK, 19 June 2023: Source Genomics, a part of the Source BioScience Group, today announced their genomic laboratory expansion into the North of the UK for increased capacity of its Sanger sequencing services leading to faster turnaround times for data delivery.
As the evolution of genomic research is dominating the collective life science industry at speed, the implementation of optimised data delivery is critical. Source Genomics is an established laboratory service partner with a vast portfolio of…
Well done to all six teams from Domainex who took on the 3 Peaks challenge to raise money for Tŷ Hafan! This amazing charity helps life-limited children in Wales to make the most of the time they have left together with their families.
There is still time to donate: https://www.justgiving.com/team/Domainex3peaks?invite=true
Bicycle Therapetuics and MRC Laboratory of Molecular Biology have shared a recent publication in Nature Communications describing the effectiveness of Bicycles as antivirals against SARS-CoV-2.
Read the full publication here: https://www.nature.com/articles/s41467-023-39158-1.epdf?sharing_token=M…
Discover state-of-the-art Category II wet lab space, co-loacted with world experts in vaccines and stemcells at the Royal Veterinary College's (RVC) Centre for Vaccinology and Regenerative Medicine (CVRM) in the beautiful Hertfordshire countryside.
Read more: https://www.lbic.com/lbic-cvrm
17 June 2023
Professor Ian Charles, Director of the Quadram Institute in Norwich, UK, has been recognised for a lifetime of pioneering research with an OBE (Order of the British Empire) in the King’s birthday honours.
Prof Charles has been awarded his OBE for Services to science and clinical research during a distinguished career in the biomedical sector. An internationally recognised academic scientist, entrepreneur and business leader, Ian has more than 30 years’ experience in academic and commercial research with a focus on infectious diseases, the microbiome, and…
ValiRx PLC, a life science company focused on early-stage cancer therapeutics and women’s health, has announced the acquisition of the scientific assets of Imagen Therapeutics Limited from its appointed liquidators for £170,000.
UK pharmaceutical services company Imagen offered personalised cancer treatment through the collection and use of well-characterised, patient-derived cells.
The company collected samples from patients over a number of years across a wide variety of cancers and was able to build a unique ‘biobank’ of human derived cells and provide services to the global pharmaceutical…